Barrow, Hanley, Mewhinney & Strauss
NRC icon

Barrow, Hanley, Mewhinney & Strauss’s NRC Health Common Stock NRC Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-47
Closed -$882 – 407
2025
Q4 		$882 Buy
47
+5
+12% +$75 ﹤0.01% 337
2025
Q3 		$537 Buy
42
+2
+5% +$30 ﹤0.01% 349
2025
Q2 		$672 Buy
+40
New +$540 ﹤0.01% 310

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's NRC Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of NRC Health Common Stock (NRC) in Q1 2026, closing a stake of 47 shares — an estimated $882 sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in NRC in Q2 2025 and held it in 3 quarters. The position peaked at $882 in Q4 2025. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining NRC Health Common Stock position as of Q1 2026 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 47 NRC Health Common Stock shares in Q1 2026, an estimated $882.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in NRC Health Common Stock in Q2 2025 and held it in 3 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's NRC Health Common Stock position peaked at $882 in Q4 2025.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.